Ebos Group Ltd (EBOSF)
28.25
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Ebos Group Enterprise Value: 6.156B for Sept. 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 27, 2024 | 6.156B |
| September 26, 2024 | 6.156B |
| September 25, 2024 | 6.156B |
| September 24, 2024 | 6.156B |
| September 23, 2024 | 6.156B |
| September 20, 2024 | 6.156B |
| September 19, 2024 | 6.156B |
| September 18, 2024 | 6.121B |
| September 17, 2024 | 6.121B |
| September 16, 2024 | 6.121B |
| September 13, 2024 | 6.115B |
| September 12, 2024 | 6.115B |
| September 11, 2024 | 6.115B |
| September 10, 2024 | 6.115B |
| September 09, 2024 | 6.115B |
| September 06, 2024 | 6.115B |
| September 05, 2024 | 6.115B |
| September 04, 2024 | 6.115B |
| September 03, 2024 | 6.115B |
| August 30, 2024 | 6.115B |
| August 29, 2024 | 6.115B |
| August 28, 2024 | 6.115B |
| August 27, 2024 | 6.115B |
| August 26, 2024 | 6.115B |
| August 23, 2024 | 6.115B |
| Date | Value |
|---|---|
| August 22, 2024 | 6.115B |
| August 21, 2024 | 6.115B |
| August 20, 2024 | 6.115B |
| August 19, 2024 | 6.115B |
| August 16, 2024 | 6.115B |
| August 15, 2024 | 6.115B |
| August 14, 2024 | 6.115B |
| August 13, 2024 | 6.115B |
| August 12, 2024 | 6.115B |
| August 09, 2024 | 6.115B |
| August 08, 2024 | 6.115B |
| August 07, 2024 | 6.115B |
| August 06, 2024 | 6.115B |
| August 05, 2024 | 6.115B |
| August 02, 2024 | 6.115B |
| August 01, 2024 | 6.115B |
| July 31, 2024 | 6.115B |
| July 30, 2024 | 6.115B |
| July 29, 2024 | 6.115B |
| July 26, 2024 | 6.115B |
| July 25, 2024 | 6.115B |
| July 24, 2024 | 6.115B |
| July 23, 2024 | 6.115B |
| July 22, 2024 | 6.115B |
| July 19, 2024 | 6.115B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.838B
Minimum
Oct 12 2023
6.438B
Maximum
Jun 18 2024
6.199B
Average
6.121B
Median
Sep 16 2024
Enterprise Value Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | 9.562M |
| Immutep Ltd | -- |
| Opthea Ltd | 171.85M |
| Mesoblast Ltd | -- |
Enterprise Value Related Metrics
| Earnings Yield | 3.30% |
| Operating Earnings Yield | 5.87% |
| Normalized Earnings Yield | 3.327 |